EDN1 and endothelial dysfunction: TMAO has been additionally characterized as a precursor of endothelial dysfunction by reducing the expression of endothelial nitric oxide synthase (eNOS), decreasing nitric oxide (NO) production, and increasing levels of endothelin-1 (ET-1) [5].